Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,938 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity.
Gamboa Vargas J, Wagner J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Peña Mosca J, Haack S, Dahlhoff J, Büttner-Herold M, Graf C, Viera EA, Einsele H, Wajant H, Beilhack A. Gamboa Vargas J, et al. Among authors: wagner j. Front Immunol. 2023 Dec 18;14:1352525. doi: 10.3389/fimmu.2023.1352525. eCollection 2023. Front Immunol. 2023. PMID: 38164131 Free PMC article.
A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity.
Vargas JG, Wagner J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Mosca JP, Haack S, Dahlhoff J, Büttner-Herold M, Graf C, Viera EA, Einsele H, Wajant H, Beilhack A. Vargas JG, et al. Among authors: wagner j. Front Immunol. 2022 Jun 13;13:888274. doi: 10.3389/fimmu.2022.888274. eCollection 2022. Front Immunol. 2022. PMID: 35769484 Free PMC article.
TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.
Siegmund D, Wagner J, Wajant H. Siegmund D, et al. Among authors: wagner j. Cancers (Basel). 2022 Aug 22;14(16):4055. doi: 10.3390/cancers14164055. Cancers (Basel). 2022. PMID: 36011046 Free PMC article. Review.
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Rohner R, Strbian D, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Gattringer T, Sandset EC, Bonati L, Aguiar de Sousa D, Sylaja PN, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein NM, Kelly P, Katan M, Horvath T, Dawson J, Fischer U; ELAN Investigators. Goeldlin MB, et al. JAMA Neurol. 2024 May 28:e241450. doi: 10.1001/jamaneurol.2024.1450. Online ahead of print. JAMA Neurol. 2024. PMID: 38805207
Moving the needle for oncology dose optimization: A call for action.
Venkatakrishnan K, Jayachandran P, Seo SK, van der Graaf PH, Wagner JA, Gupta N. Venkatakrishnan K, et al. Among authors: wagner ja. CPT Pharmacometrics Syst Pharmacol. 2024 May 22. doi: 10.1002/psp4.13157. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38778466 Free article. No abstract available.
5,938 results